BDRX
Biodexa Pharmaceuticals
BDRX
BDRX
5 hedge funds and large institutions have $28.1K invested in Biodexa Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$24.9K |
| 2 |
GI
GAMMA Investing
Foster City,
California
|
$1.88K |
| 3 |
Morgan Stanley
New York
|
$924 |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
$414 |
Top Sellers
| 1 |
SS
SBI Securities
Tokyo,
Japan
|
$1 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $24.9K | +$15.6K | +1,178 | +167% |
|
|
GI
2
GAMMA Investing
Foster City,
California
| $1.88K | +$1.88K | +143 | New |
|
|
3
Morgan Stanley
New York
| $924 | +$924 | +70 | New |
|
|
4
RhumbLine Advisers
Boston,
Massachusetts
| $414 | +$220 | +17 | +113% |
|
|
CIM
5
Contravisory Investment Management
Norwell,
Massachusetts
| $53 | – | – | – |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $1 | -$4 | – | – |
|